*Takafumi Shimada¹ (1. Juntendo University Graduate School of Medicine)

*Gokulakrishnan Kuppan¹, Chinnasamy Thirumoorthy¹, Deepa Mohan⁴, Venkatesan U⁴, Shallu Durai¹, Nikhil PJ¹, Pavithra R¹, Anjana Ranjith Mohan⁴, UMARAM UMARAM⁵, Srikumar BN², Balasubramanyam M⁴, Saravanan P⁶, Mohan V⁴, Govindaraj P³ (1. Department of Neurochemistry, National Institute of Mental Health and Neuro Sciences (NIMHANS), Bengaluru, India, 2. Department of Neurophysiology, National Institute of Mental Health and Neuro Sciences (NIMHANS), Bengaluru, India, 3. Department of Neuropathology, National Institute of Mental Health and Neuro Sciences (NIMHANS), Bengaluru, India, 4. Department of Diabetology, Madras Diabetes Research Foundation (MDRF), Chennai, India, 5. Seethapathy Clinic & Hospital, Chennai, India, 6. Populations, Evidence and Technologies, Division of Health Sciences, Warwick Medical School, University of Warwick, UK)

*Satoshi Yoshinaga^1,2, Julio Leon^3,4, Mizuki Hino^5,6, Yoshinari Ando³, Jonathan Moody³, Atsuko Nagaoka^5,7, Ayako Kitazawa^1,2, Kanehiro Hayashi², Kazunori Kazunori², Chung Chau Hon³, Yasuto Kunii^5,6, Jay W. Shin^3,8, Ken-ichiro Kubo^1,2 (1. The Jikei Univ Sch of Med, Tokyo, Japan, 2. Keio Univ Sch of Med, Tokyo, Japan, 3. IMS RIKEN, Yokohama, Japan, 4. Inst. for Neurodegenerative Diseases, UCSF, San Francisco, USA, 5. Dept of Neuropsych, Fukushima Med Univ, Fukushima, Japan, 6. Dept of Disaster Psych, IRIDeS, Tohoku Univ, Sendai, Japan, 7. Dep of Psych, Tohoku Univ Hospital, Sendai, Japan, 8. Lab. of Regulatory Genomics, Genome Inst. of Singapore, A*STAR, Singapore)

*Shinji Sakamoto^1,2, Xiaolei Zhu², Ishii Chiharu³, Matthew D Smith⁴, Ito Koki^5,2, Mizuho Obayashi², Lisa Unger⁶, Yuto Hasegawa², Shunya Kurokawa⁷, Taishiro Kishimoto^7,8, Hui Li^9,10, Shinya Hatano¹¹, Jeff Wang⁹, Yasunobu Yoshikai¹¹, Shin-ichi Kano¹², Shinji Fukuda^3,13,14,15, Kenji Sanada¹⁶, Peter A Calabresi^4,17, Atsushi Kamiya² (1. Dept Neuropsychiatry, Okayama Univ Hosp, Okayama, Japan, 2. Dept Psychiatry and Behavioral Sciences, Johns Hopkins Univ Sch Med, Baltimore, USA, 3. Inst Advanced Biosciences, Keio Univ, Tokyo, Japan, 4. Dept Neurology, Johns Hopkins Univ Sch Med, Baltimore, USA, 5. Dept Psychiatry, Hokkaido Univ Grad Sch Med, Hokkaido, Japan, 6. Inst Neuroimmunology and Multiple Sclerosis, University Medical Centre Hamburg–Eppendorf, Hamburg, Germany, 7. Dept Neuropsychiatry, Keio Univ Sch Med, Tokyo, Japan, 8. Hills Joint Research Laboratory for Future Preventive Medicine and Wellness, Keio Univ Sch Med, Tokyo, Japan, 9. Dept Mechanical Engineering and Biomedical Engineering, Johns Hopkins Univ, Baltimore, USA, 10. Sch Electrical, Computer and Biomedical Engineering, Southern Illinois Univ, Carbondale, USA, 11. Med Inst Bioregulation, Kyushu Univ, Fukuoka, Japan, 12. Dept Psychiatry and Behavioral Neurobiology, Univ Alabama at Birmingham Heersink Sch Med, Birmingham, USA, 13. Gut Environmental Design Group, Kanagawa Inst Industrial Science and Technology, Kawasaki, Japan. , 14. Transborder Medical Research Center, Univ Tsukuba, Tsukuba, Japan, 15. Lab Regenerative Microbiology, Grad Sch Med, Juntendo Univ, Tokyo, Japan, 16. Dept Psychiatry, Sch Med, Showa Univ, Tokyo, Japan, 17. Dept Neuroscience, Johns Hopkins Univ Sch Med, Baltimore, USA)